@Gator_TheTrader 🤔 and just like that, I stand corrected on my belief that dilution would only occur beyond the $8.30 SP point… 🤷🏻♂️ Good thing… Fundamentals of the company remain the same!!! Conviction and Paytience remains strong!!
@Gator_TheTrader I agree that dilution is inevitable until such time Biora can generate sales revenue and becomes profitable. However, do keep in mind that current prospective dilution will not start until the SP surpasses $8.30, which is the price point of the active warrants now outstanding…
@Antonio65489262 @MDUnderground Great find!!
It’s not just important to them before their product is marketed/commercialized; most importantly, it is yet one more intellectual asset to the company that will greatly increase market value and also provide market exclusivity for years to come! It’s huge! 🚀🚀🚀
@Gator_TheTrader At the end of the day… Nothing has changed in the fundamentals of the company! My conviction remains high and my paytience is strong!! I’ve averaged down to the $1.30 range and should the SP continue to stay here, I will avg down further to be below $1
@Gator_TheTrader That’s correct! The company’s ability to RS is an essential part of having the chance to extend the additional 180 days which will give the stock until sometime in June 2023 to be above $1
The RS vote HAS to be approved now in order to prevent de-listing by Nasdaq
@BioraThera $BIOR Adi was appointed CEO of Progenity (now Biora) on November 8th 2021. The SP was around $3.72…in a little over a year he has overseen a drop to the NEWEST all time low of the sp to $0.1851…how does he continue to have a job? Your shareholders want ANSWERS!
@TRUExDEMON I have avg down from $3.41 down to $1.23, while increasing from 7k shares to 21k shares… I have both done extensive DD and have gather addt info from many - including TruexDemon, who’s insights I value. At the end of the day, it’s my conviction & paytience that will pay off!!!